Dr. Habela completed a Medical Scientist Training Program at the University of Alabama, Birmingham. She received her PhD in Neurobiology in 2008 and her MD in 2010. After medical school, she specialized in child neurology, and completed 2 years of pediatrics residency and 3 years of child neurology residency at the Johns Hopkins Hospital in 2015. She then completed another 2 years of training specifically focused on the diagnosis, characterization and medical and surgical management of patients with epilepsy during an Epilepsy Fellowship at Johns Hopkins. Dr. Habela’s clinic specializes in pediatric neurology and epilepsy. Her clinical focus in on the care of patients with severe epilepsy with or without other neurodevelopmental disorders that have not been easily controlled with medications. She is also focused on the genetic causes of epilepsy and other neurodevelopmental disabilities with the hope that increasing our understanding of the genetic causes of epilepsy and neurodevelopmental disabilities will improve treatment. Dr. Habela’s basic science research is focused on the genetic mechanisms regulating appropriate proliferation, migration and integration of neurons and glial cells in both the prenatal and postnatal developing brain and how aberrations in these processes result in neurodevelopmental disabilities. Her hypothesis is that deregulation of pre and postnatal neurogenesis and synaptogenesis contributes to the behavioral phenotypes observed in many forms of intellectual disability, epilepsy and autism. Her research applies what we know from human genetic studies to basic science studies examining how specific genetic changes alter neurogenesis, synaptogenesis and overall excitation / inhibition balance in laboratory model systems. Her goal is to provide a better understanding of the molecular mechanisms of these processes and, in turn, possibly identify specific targets for disease modifying treatments for epilepsy. Contact for Research Inquiries 600 N. Wolfe Street Meyer 2-147 Baltimore, MD 21287 Phone: (410) 955-9100. Dr. Habela is rated as an Elite provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Epilepsy, and Endovascular Embolization.

Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as an Elite provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Arens Taga is a neurologist specializing in neuromuscular diseases, with a particular focus on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. His clinical work aims to improve the quality of care for patients with ALS through biomarker-based, precision medicine approaches that refine disease stratification and facilitate more targeted and efficient enrollment in clinical trials. As a clinician-scientist, Dr. Taga uses patient-derived induced pluripotent stem cells to model ALS, uncover novel disease mechanisms and identify therapeutic targets that are translatable to clinical trials. In recognition of his work in ALS, Dr. Taga was awarded the 2025 Richard Olney Clinician Scientist Development Award, which honors early-career physician-scientists dedicated to advancing ALS research. Dr. Taga earned his medical degree from the School of Medicine and Surgery at the University of Parma, Italy, where he also completed his neurology residency. He subsequently trained at The Johns Hopkins University, completing a postdoctoral research fellowship in the neuromuscular division, an internal medicine internship, a neurology residency and a neuromuscular clinical fellowship. Dr. Taga is rated as an Elite provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Cluster Headache.

. Dr. Anand is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are Pulmonary Valve Stenosis, Pulmonary Supravalvular Stenosis, Patent Ductus Arteriosus, and Familial Dilated Cardiomyopathy.

Chih-ping Chen practices in Taiwan. Chen is rated as an Elite expert by MediFind in the treatment of 15q11.2 Microdeletion. Their top areas of expertise are Trisomy 14 Mosaicism, Trisomy 18, Hygroma Cervical, and Mosaic Trisomy 8.

Merlin Butler is a Medical Genetics specialist and a Pediatrics provider in Kansas City, Kansas. Dr. Butler is rated as an Elite provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Prader-Willi Syndrome, Hypotonia, 15q11.2 Microdeletion, Hormone Replacement Therapy (HRT), and Sleeve Gastrectomy. Dr. Butler is currently accepting new patients.

. Dr. Russi is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Increased Head Circumference, Ehlers-Danlos Syndrome (EDS), Chromosome 8p Deletion, and Chromosome 6q Duplication.

Jonathan Kopelovich, MD, is a board-certified otolaryngologist, who cares for problems that affect the head, neck, ear, nose and throat. He has additional board-certification and fellowship training in complex pediatric otolaryngology and has extensive experience in airway, craniofacial and ear surgery for children. Dr. Kopelovich believes in a collaborative and holistic approach to caring for every child.Raised on the gulf coast of Florida, Dr. Kopelovich pursued higher education in Philadelphia. He graduated cum laude from the University of Pennsylvania, then attended Jefferson Medical College and spent an additional year at the Children’s Hospital of Philadelphia devoted to cochlear implant research in children.Inspired by these experiences, Dr. Kopelovich completed otolaryngology residency and a neurobiology research fellowship at the University of Iowa, followed by a fellowship year in pediatric ENT at the Children’s Hospital of Colorado. While training, he focused on diseases affecting breathing, sleep, facial development and hearing. In addition to a stellar publication record, Dr. Kopelovich is passionate about decreasing the environmental impact of medicine. Since starting in practice with Bellevue Ear Nose and Throat, Dr. Kopelovich has organized and led multiple interdisciplinary provider groups in King County to help coordinate care for children with complicated head and neck issues. Additionally, he serves as the pediatric otolaryngology consultant for four neonatal ICUs.Dr. Kopelovich lives on Mercer Island with his wife, Rachel, a Seattle native and acupuncturist, and their three children. He enjoys hiking and skiing with his family in the Cascades and is an avid fan of all elements of hip hop culture. Dr. Kopelovich is rated as an Experienced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Hearing Loss, Enlarged Adenoids, Stridor, and Low Nasal Bridge.

. Dr. Snyder is rated as an Experienced provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are Obesity in Children, Delayed Growth, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), and Increased Head Circumference.

Michal Szczodry is an Orthopedics provider in Orland Park, Illinois. Dr. Szczodry is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Scoliosis, Sciatica, Distal 18q Deletion Syndrome, Microdiscectomy, and Herniated Disc Surgery.

Nicholas Sala is an Ophthalmologist in Erie, Pennsylvania. Dr. Sala is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Strabismus, Esotropia, Amblyopia, and Chalazion.

Leemor Rotberg is an Ophthalmologist in West Bloomfield, Michigan. Dr. Rotberg has been practicing medicine for over 26 years and is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, and Esotropia. Dr. Rotberg is currently accepting new patients.

Stephen Lewis is a Neurologist in Willow Grove, Pennsylvania. Dr. Lewis is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Progressive Myoclonic Epilepsy, Unverricht-Lundborg Syndrome, Lafora Disease, and Dravet Syndrome. Dr. Lewis is currently accepting new patients.

James Daley is a Physiatrist in Center Valley, Pennsylvania. Dr. Daley is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Distal 18q Deletion Syndrome, 15q11.2 Microdeletion, Jacobsen Syndrome, and Stroke.

Sumit Parikh is a Pediatric Neurologist in Cleveland, Ohio. Dr. Parikh has been practicing medicine for over 32 years and is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Kearns-Sayre Syndrome, Maternally Inherited Leigh Syndrome, Leigh Syndrome, and MELAS Syndrome.

Erica Fernandes is a Medical Genetics specialist and a Pediatrics provider in New Hyde Park, New York. Dr. Fernandes is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are Microcephaly, Chromosome 13q Deletion, Scalp-Ear-Nipple Syndrome, and Snyder-Robinson Syndrome.

Alan Norman is an Ophthalmologist in Fort Worth, Texas. Dr. Norman is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Strabismus, Esotropia, Epicanthal Folds, and Micropthalmia Associated with Colobomatous Cyst.

Jay Shah is a Pediatric Otolaryngologist and an Otolaryngologist in Westlake, Ohio. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Laryngomalacia, Subglottic Stenosis, Enlarged Adenoids, Stridor, and Adenoidectomy. Dr. Shah is currently accepting new patients.

Irina Trosman is a Pediatrics specialist and a Pulmonary Medicine provider in Chicago, Illinois. Dr. Trosman is rated as an Experienced provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are Obstructive Sleep Apnea, Sleepwalking (Somnambulism), Irregular Sleep-Wake Syndrome, and Narcolepsy.

Prithvi Mruthyunjaya is an Ophthalmologist in Stanford, California. Dr. Mruthyunjaya is rated as an Experienced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Melanoma of the Eye, Uveal Melanoma, Retinal Detachment, Vitrectomy, and Trabeculectomy.